149 related articles for article (PubMed ID: 30897548)
21. Plurihormonality of pituitary adenomas in light of immunohistochemical studies.
Pawlikowski M; Kunert-Radek J; Radek M
Endokrynol Pol; 2010; 61(1):63-6. PubMed ID: 20205106
[TBL] [Abstract][Full Text] [Related]
22. Thyrotropin Secreting Pituitary Adenoma: A Clinical Case of Postoperative Re-Onset Thyrotoxicosis with Adenoma Recurrence.
Maia A; Cidade Rodrigues C; Ribeiro I; Amaral C
Eur J Case Rep Intern Med; 2023; 10(6):003905. PubMed ID: 37305007
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis, pathology, and management of TSH-secreting pituitary tumors. A single-center retrospective study of 20 patients from 1981 to 2014.
Căpraru OM; Gaillard C; Vasiljevic A; Lasolle H; Borson-Chazot F; Raverot V; Jouanneau E; Trouillas J; Raverot G
Ann Endocrinol (Paris); 2019 Sep; 80(4):216-224. PubMed ID: 31400861
[TBL] [Abstract][Full Text] [Related]
24. Silent pituitary plurihormonal adenoma: clinical relevance of immunohistochemical analysis.
García-Sáenz M; Uribe-Cortés D; González-Virla B; Mendoza-Zubieta V; Vargas-Ortega G
Rev Med Inst Mex Seguro Soc; 2019 Apr; 57(1):48-55. PubMed ID: 31071255
[TBL] [Abstract][Full Text] [Related]
25. Plurihormonal pituitary adenoma with concomitant adrenocorticotropic hormone (ACTH) and growth hormone (GH) secretion: a report of two cases and review of the literature.
Rasul FT; Jaunmuktane Z; Khan AA; Phadke R; Powell M
Acta Neurochir (Wien); 2014 Jan; 156(1):141-6. PubMed ID: 24081787
[TBL] [Abstract][Full Text] [Related]
26. Hypersecretion of ACTH and PRL from pituitary adenoma in MEN1, adequately managed by medical therapy.
Uraki S; Ariyasu H; Doi A; Furuta H; Nishi M; Usui T; Yamaue H; Akamizu T
Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 28458907
[TBL] [Abstract][Full Text] [Related]
27. Unexpected clinical course during treatment of a TSH-secreting pituitary adenoma.
Glynn N; Agha A
Endocr Pract; 2013; 19(4):e88-91. PubMed ID: 23512395
[TBL] [Abstract][Full Text] [Related]
28. Plurihormonal pituitary adenoma immunoreactive for thyroid-stimulating hormone, growth hormone, follicle-stimulating hormone, and prolactin.
Luk CT; Kovacs K; Rotondo F; Horvath E; Cusimano M; Booth GL
Endocr Pract; 2012; 18(5):e121-6. PubMed ID: 22441009
[TBL] [Abstract][Full Text] [Related]
29. Corticotroph adenoma and pituitary fungal infection: a rare association.
Catarino D; Ribeiro C; Gomes L; Paiva I
Endocrinol Diabetes Metab Case Rep; 2020 Mar; 2020():. PubMed ID: 32213650
[TBL] [Abstract][Full Text] [Related]
30. Recurrent plurihormonal bimorphous pituitary adenoma producing growth hormone, thyrotropin, and prolactin.
Felix I; Asa SL; Kovacs K; Horvath E; Smyth HS
Arch Pathol Lab Med; 1994 Jan; 118(1):66-70. PubMed ID: 8285835
[TBL] [Abstract][Full Text] [Related]
31. Preoperative lanreotide treatment for GH-secreting pituitary adenomas: effect on tumour volume and predictive factors of significant tumour shrinkage.
Lucas T; Astorga R; Catalá M;
Clin Endocrinol (Oxf); 2003 Apr; 58(4):471-81. PubMed ID: 12641631
[TBL] [Abstract][Full Text] [Related]
32. Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas.
Mete O; Gomez-Hernandez K; Kucharczyk W; Ridout R; Zadeh G; Gentili F; Ezzat S; Asa SL
Mod Pathol; 2016 Feb; 29(2):131-42. PubMed ID: 26743473
[TBL] [Abstract][Full Text] [Related]
33. Silent subtype 3 pituitary adenoma: a clinicopathologic analysis of the Mayo Clinic experience.
Erickson D; Scheithauer B; Atkinson J; Horvath E; Kovacs K; Lloyd RV; Young WF
Clin Endocrinol (Oxf); 2009 Jul; 71(1):92-9. PubMed ID: 19170710
[TBL] [Abstract][Full Text] [Related]
34. Expression of somatostatin receptor subtypes in human pituitary adenomas -- immunohistochemical studies.
Pisarek H; Pawlikowski M; Kunert-Radek J; Radek M
Endokrynol Pol; 2009; 60(4):240-51. PubMed ID: 19753537
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
36. Plurihormonal cells of normal anterior pituitary: Facts and conclusions.
Mitrofanova LB; Konovalov PV; Krylova JS; Polyakova VO; Kvetnoy IM
Oncotarget; 2017 Apr; 8(17):29282-29299. PubMed ID: 28418929
[TBL] [Abstract][Full Text] [Related]
37. Silent somatotroph tumour revisited from a study of 80 patients with and without acromegaly and a review of the literature.
Chinezu L; Vasiljevic A; Trouillas J; Lapoirie M; Jouanneau E; Raverot G
Eur J Endocrinol; 2017 Feb; 176(2):195-201. PubMed ID: 27913611
[TBL] [Abstract][Full Text] [Related]
38. Hyperthyroidism caused by an ectopic thyrotropin-secreting tumor of the nasopharynx: a case report and review of the literature.
Tong A; Xia W; Qi F; Jin Z; Yang D; Zhang Z; Li F; Xing X; Lian X
Thyroid; 2013 Sep; 23(9):1172-7. PubMed ID: 23402621
[TBL] [Abstract][Full Text] [Related]
39. Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients.
Rimareix F; Grunenwald S; Vezzosi D; Rivière LD; Bennet A; Caron P
Thyroid; 2015 Aug; 25(8):877-82. PubMed ID: 26244412
[TBL] [Abstract][Full Text] [Related]
40. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
Teramoto A; Sanno N; Tahara S; Osamura YR
Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
